共 150 条
[1]
Wollheim FA(2005)Classification of systemic sclerosis. Visions and reality Rheumatology (Oxford) 44 1212-1216
[2]
van den Hoogen F(2013)2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative Arthritis and Rheumatism 65 2737-2747
[3]
Khanna D(2010)Epidemiology of systemic sclerosis Best Practice & Research. Clinical Rheumatology 24 857-869
[4]
Fransen J(2013)New insights in the immunobiology of IL-1 family members Frontiers in Immunology 4 167-393
[5]
Nikpour M(2013)Overview of the interleukin-1 family of ligands and receptors Semin Immunol 25 389-3005
[6]
Stevens WM(2012)IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist Proceedings of the National Academy of Sciences of the United States of America 109 3001-672
[7]
Herrick AL(1985)Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma Clinical and Experimental Immunology 59 666-89
[8]
van de Veerdonk FL(1986)Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65 80-302
[9]
Netea MG(1985)Interleukin-1 production by mononuclear cells from patients with scleroderma Clinical and Experimental Immunology 60 294-145
[10]
Dinarello CA(1986)Studies of an interleukin 1 inhibitor: characterization and clinical significance Clinical and Experimental Immunology 64 136-319